A carregar...
Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?
BACKGROUND: Current guidelines recommend adjuvant chemotherapy for resected pancreatic adeno-carcinoma (PDAC). However, no studies have addressed its survival benefit for stage I patients as they comprise <10% of PDAC. METHODS: Using the NCDB 2006–2012, resected PDAC patients with stage I disease...
Na minha lista:
| Publicado no: | HPB (Oxford) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324176/ https://ncbi.nlm.nih.gov/pubmed/28433254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2017.03.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|